NCT02738255

Brief Summary

Test the effect of added a single-use Varnum mouthpiece on pharyngeal collapsibility and obstructive sleep apnea (OSA) severity in patients who identify themselves as mouth breathers. Research indicates that nasal breathing not only may improve sleep apnea but it also increases circulation, blood oxygen, and carbon dioxide levels, slows the breathing rate, and improves overall lung volumes. Thus, the investigators will test whether a single-use Varnum mouthpiece can improve pharyngeal collapsibility and OSA severity in mouth breathers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 14, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

June 2, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2017

Completed
1 year until next milestone

Results Posted

Study results publicly available

July 3, 2018

Completed
Last Updated

April 4, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

April 12, 2016

Results QC Date

March 7, 2018

Last Update Submit

March 30, 2022

Conditions

Keywords

Obstructive sleep apneaMouth breathingApnea-Hypopnea Index (AHI)

Outcome Measures

Primary Outcomes (1)

  • Sleep Apnea Severity as Measured by Apnea-hypopnea Index (AHI)

    The number of respiratory events (apneas and hypopneas) per hour of sleep. This was measured on two nights in random order (night with Varnum mouthpiece and night without Varnum mouthpiece). The median AHI on the night with Varnum mouthpiece was then compared with median AHI on the night without Varnum mouthpiece.

    Two nights: night with Varnum mouthpiece and night without Varnum mouthpiece

Secondary Outcomes (2)

  • Pharyngeal Collapsibility as Measured by Median Peak Inspiratory Flow During Sleep

    Two nights: night with Varnum mouthpiece and night without Varnum mouthpiece

  • Snoring Index in Simple Snorers

    Two nights: night with Varnum mouthpiece and night without Varnum mouthpiece

Study Arms (2)

Polysomnogram With Varnum First, Regular Polysomnogram Second

ACTIVE COMPARATOR

Varnum mouthpiece, similar to a mouth tape with central opening on the first night, then a 1-week non-treatment period, then overnight sleep study with no mouthpiece.

Device: Varnum mouthpiece

Regular Polysomnogram First, Polysomnogram With Varnum Second

ACTIVE COMPARATOR

Baseline sleep study without Varnum mouthpiece on the first night, then a 1-week non-treatment period, then an overnight sleep study with Varnum mouthpiece on the second night.

Device: Varnum mouthpiece

Interventions

An adhesive mouthpiece with a central opening applied during sleep

Also known as: Somnifix mouthpiece
Polysomnogram With Varnum First, Regular Polysomnogram SecondRegular Polysomnogram First, Polysomnogram With Varnum Second

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of obstructive sleep apnea (AHI\>10 events/hr)

You may not qualify if:

  • Serious co-morbidities including lung disease, heart disease, renal disease
  • Medications affecting respiration or sleep

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep Disorders Research Program Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveMouth Breathing

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Andrew Wellman
Organization
Brigham and Women's Hospital

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 12, 2016

First Posted

April 14, 2016

Study Start

June 2, 2016

Primary Completion

June 15, 2017

Study Completion

June 15, 2017

Last Updated

April 4, 2022

Results First Posted

July 3, 2018

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

Locations